MetLife outlines 2026 governance roadmap, shares tracked against S&P 500 insurers

MetLife has confirmed the results of its June 2026 shareholder meeting, setting board, auditor and pay policies for the coming year, while NYSE-listed shares trade in the U.S. large-cap financials segment alongside peers like Prudential and AIG.

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-23, 22:11.

MetLife Inc. (US59156R1086) has confirmed a slate of governance decisions following its June 16, 2026 annual meeting of common shareholders, while the NYSE-listed insurer continues to trade within the U.S. large-cap financials universe alongside peers such as Prudential Financial and AIG. According to a summary of the meeting decisions, the outcomes set MetLife’s board composition, auditor mandate and executive pay framework for the 2026 financial year.

What the meeting decided

The June 16 MetLife shareholder meeting elected eleven directors to serve terms expiring at the 2027 annual meeting, maintaining continuity at the top of the U.S. life insurer’s governance structure, according to the meeting results. The same summary notes that shareholders ratified Deloitte & Touche LLP as independent auditor for fiscal 2026, extending a long-standing audit relationship focused on U.S. GAAP and statutory reporting for the NYSE- and S&P 500-listed group.

In addition, investors approved, on an advisory and non-binding basis, compensation for the company’s Named Executive Officers as set out in the 2026 proxy statement, signaling support for MetLife’s pay-for-performance policy design in areas such as return on equity and free cash flow. The governance package arrives roughly six weeks after MetLife reported first-quarter 2026 adjusted earnings per share of 2.42 U.S. dollars, beating the consensus estimate of 2.27 dollars, as collated by MarketBeat’s earnings overview for MET.

How MetLife compares in the sector

MetLife shares trade on the New York Stock Exchange under the ticker MET, placing the company among major U.S. life and retirement carriers such as Prudential Financial and Lincoln National in the S&P 500 financials cohort. According to MarketBeat’s latest quote snapshot on June 22, 2026, MetLife shares closed at 87.50 U.S. dollars, up 2.25 percent on the day, with extended trading indications at 87.21 dollars as of 05:36 Eastern Time in the same dataset.

The same MarketBeat overview reports that MetLife’s recent quarterly earnings beat and capital-return program, including a regular common dividend, are part of the sector’s broader trend of returning excess capital amid higher interest rates. Sector watchers interviewed by Reuters and other outlets have highlighted that life insurers’ investment portfolios, typically heavy in investment-grade fixed income, tend to benefit from higher reinvestment yields, even as equity market volatility can affect variable annuity and fee-based businesses.

Where MetLife earns its money

MetLife generates most of its revenue from insurance premiums, investment income and fees across U.S. Group Benefits, Retirement & Income Solutions and its international businesses. The group distributes life, dental, disability, accident and other protection products to employers and individuals, alongside annuities and pension-risk transfer solutions that convert corporate defined-benefit obligations into insurance contracts.

Where the MetLife shares trade today

The MetLife shares (US59156R1086) trade on the NYSE under the ticker MET; according to MarketBeat data referenced above, they last closed at 87.50 U.S. dollars as of 2026-06-22, 15:59 Eastern Time.

Key data on the MetLife shares

• Company: MetLife, Inc.
• ISIN: US59156R1086
• WKN: 938030
• Ticker: MET
• Trading venue: NYSE
• Price (as of 2026-06-22, 15:59): 87.50 USD
• Market cap: 62.7 billion USD (as of 2026-06-22)
• Sector / industry: Financials / Life & Health Insurance
• Index membership: S&P 500
• Next earnings date: 2026-08-01

This article is for informational purposes only and does not constitute investment advice, an offer or solicitation to buy or sell securities, or a recommendation for any specific investment strategy. Historical performance is not a reliable indicator of future results.